MyD88-dependent induction of allergic Th2 responses to intranasal antigen

Journal of Clinical Investigation

Volumn 115, Issue 2, 2005, Pages 459-467

  Piggott, Damani A ^a   Eisenbarth, Stephanie C ^a   Xu, Lan ^a   Constant, Stephanie L ^b   Huleatt, James W ^a   Herrick, Christina A ^a   Bottomly, Kim ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; OVALBUMIN; TOLL LIKE RECEPTOR; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; IMMUNOGLOBULIN RECEPTOR; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE, E COLI O55 B5; LIPOPOLYSACCHARIDE, E COLI O55-B5; MYD88 PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TLR4 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 4;

ALLERGY; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN DETECTION; ARTICLE; B LYMPHOCYTE; BINDING SITE; CELL TRANSFER; CELLULAR IMMUNITY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; IMMUNE RESPONSE; IMMUNOREGULATION; LUNG DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN INDUCTION; REGULATORY MECHANISM; TH1 CELL; TH2 CELL; ADOPTIVE IMMUNOTHERAPY; ANIMAL; BAGG ALBINO MOUSE; BONE MARROW CELL; DENDRITIC CELL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HYPERSENSITIVITY; IMMUNOLOGY; INNATE IMMUNITY; INTRANASAL DRUG ADMINISTRATION; LUNG; LYMPHOCYTE ACTIVATION; MOUSE MUTANT; PATHOLOGY; SIGNAL TRANSDUCTION; TRANSPLANTATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIGENS, DIFFERENTIATION; BONE MARROW CELLS; DENDRITIC CELLS; GENE EXPRESSION REGULATION; HYPERSENSITIVITY; IMMUNITY, NATURAL; IMMUNOTHERAPY, ADOPTIVE; LIPOPOLYSACCHARIDES; LUNG; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; OVALBUMIN; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TH2 CELLS; TOLL-LIKE RECEPTOR 4;

EID: 14944375918     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200522462     Document Type: Article

References (44)

1. Constant, S.L., and Bottomly, K. 1997. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:297-322.
2. Eisenbarth, S.C., Piggott, D.A., and Bottomly, K. 2003. The master regulators of allergic inflammation: dendritic cells in Th2 sensitization. Curr. Opin. Immunol. 15:620-626.
3. Lenschow, D.J., Walunas, T.L., and Bluestone, J.A. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233-258.
4. Sharpe, A.H., and Freeman, G.J. 2002. The B7-CD28 superfamily. Nat. Rev. Immunol. 2:116-126.
5. Janeway, C.A., Jr., and Medzhitov, R. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197-216.
6. Janeway, C.A., Jr. 1989. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54:1-13.
7. Takeda, K., Kaisho, T., and Akira, S. 2003. Toll-like receptors. Annu. Rev. Immunol. 21:335-376.
8. Medzhitov, R., et al. 1998. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell. 2:253-258.
9. Muzio, M., Natoli, G., Saccani, S., Levrero, M., and Mantovani, A. 1998. The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J. Exp. Med. 187:2097-2101.
10. Yamamoto, M., Takeda, K., and Akira, S. 2004. TIR domain-containing adaptors define the specificity of TLR signaling. Mol. Immunol. 40:861-868.
11. Barton, G.M., and Medzhitov, R. 2003. Toll-like receptor signaling pathways. Science. 300:1524-1525.
12. Kaisho, T., et al. 2002. Endotoxin can induce MyD88-deficient dendritic cells to support T(h)2 cell differentiation. Int. Immunol. 14:695-700.
13. Schnare, M., et al. 2001. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2:947-950.
14. Muraille, E., et al. 2003. Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response. J. Immunol. 170:4237-4241.
15. Jankovic, D., et al. 2002. In the absence of IL-12, CD4(+) T cell responses to intracellular pathogens fail to default to a Th2 pattern and are host protective in an IL-10(-/-) setting. Immunity. 16:429-439.
16. Barton, G.M., and Medzhitov, R. 2002. Control of adaptive immune responses by Toll-like receptors. Curr. Opin. Immunol. 14:380-383.
17. Eisenbarth, S.C., et al. 2002. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 196:1645-1651.
18. Dabbagh, K., Dahl, M.E., Stepick-Biek, P., and Lewis, D.B. 2002. Toll-like receptor 4 is required for optimal development of Th2 immune responses: role of dendritic cells. J. Immunol. 168:4524-4530.
19. Kawai, T., Adachi, O., Ogawa, T., Takeda, K., and Akira, S. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 11:115-122.
20. Kawai, T., et al. 2001. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 167:5887-5894.
21. Kaisho, T., Takeuchi, O., Kawai, T., Hoshino, K., and Akira, S. 2001. Endotoxin-induced maturation of MyD88-deficient dendritic cells. J. Immunol. 166:5688-5694.
22. Yamamoto, M., et al. 2002. Cutting edge: a novel Toll/ IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J. Immunol. 169:6668-6672.
23. Hoebe, K., et al. 2003. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature. 424:743-748.
24. Yamamoto, M., et al. 2003. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science. 301:640-643.
25. Herrick, C.A., MacLeod, H., Glusac, E., Tigelaar, R.E., and Bottomly, K. 2000. Th2 responses induced by epicutaneous or inhalational protein exposure are differentially dependent on IL-4. J. Clin. Invest. 105:765-775.
26. Kung, T.T., et al. 1994. Characterization of a murine model of allergic pulmonary inflammation. Int. Arch. Allergy Immunol. 105:83-90.
27. Kimber, I., and Cumberbatch, M. 1992. Stimulation of Langerhans cell migration by tumor necrosis factor alpha (TNF-alpha). J. Invest. Dermatol. 99(Suppl.):48S-50S.
28. Roake, J.A., et al. 1995. Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J. Exp. Med. 181:2237-2247.
29. Sallusto, F., Mackay, C.R., and Lanzavecchia, A. 2000. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 18:593-620.
30. Banchereau, J., et al. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767-811.
31. Constant, S.L., et al. 2002. Resident lung antigen-presenting cells have the capacity to promote Th2 T cell differentiation in situ. J. Clin. Invest. 110:1441-1448. doi:10.1172/JCI200216109.
32. Akimoto, T., et al. 1998. Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT)6-deficient mice. J. Exp. Med. 187:1537-1542.
33. Busse, W.W., and Lemanske, R.F., Jr. 2001. Asthma. N. Engl. J. Med. 344:350-362.
34. Henderson, W.R., Jr., et al. 1996. The importance of leukotrienes in airway inflammation in a mouse model of asthma. J. Exp. Med. 184:1483-1494.
35. Wills-Karp, M. 1999. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17:255-281.
36. Kaisho, T., and Akira, S. 2003. Regulation of dendritic cell function through Toll-like receptors. Curr. Mol. Med. 3:373-385.
37. Hoebe, K., et al. 2003. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat. Immunol. 4:1223-1229.
38. Didierlaurent, A., et al. 2004. Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response. J. Immunol. 172:6922-6930.
39. Pasare, C., and Medzhitov, R. 2003. Toll-like receptors: balancing host resistance with immune tolerance. Curr. Opin. Immunol. 15:677-682.
40. Pasare, C., and Medzhitov, R. 2003. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science. 299:1033-1036.
41. Adachi, O., et al. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity. 9:143-150.
42. Cohn, L., Homer, R.J., Niu, N., and Bottomly, K. 1999. T helper 1 cells and interferon gamma regulate allergic airway inflammation and mucus production. J. Exp. Med. 190:1309-1318.
43. Seymour, B.W., Gershwin, L.J., and Coffman, R.L. 1998. Aerosol-induced immunoglobulin (Ig)-E unresponsiveness to ovalbumin does not require CD8+ or T cell receptor (TCR)-gamma/delta+ T cells or interferon (IFN)-gamma in a murine model of allergen sensitization. J. Exp. Med. 187:721-731.
44. Lutz, M.B., et al. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods. 223:77-92.